Bernhard Weingärtner

Title: Bernhard Weingärtner: Innovator in Acylglycerol Acyltransferase Research

Introduction

Bernhard Weingärtner is a notable inventor based in Wülfrath, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of acylglycerol acyltransferase-like proteins. With a total of 2 patents, his work has implications for various medical conditions.

Latest Patents

Weingärtner's latest patents focus on the acylglycerol acyltransferase-like protein MGAT-X1. The first patent describes a polynucleotide sequence of this novel protein, which is associated with several dermatological, urological, and neurological diseases, among others. The invention also includes assays for identifying compounds that can modulate these diseases, as well as pharmaceutical compositions that contain such compounds. This research holds promise for treating conditions linked to the expression of MGAT-X1.

Career Highlights

Throughout his career, Bernhard Weingärtner has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Pharma Aktiengesellschaft. His experience in these organizations has contributed to his expertise in the field of biochemistry and patent development.

Collaborations

Weingärtner has collaborated with notable colleagues such as Stefan Golz and Ulf Brüggemeier. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Bernhard Weingärtner's contributions to the field of acylglycerol acyltransferase research are significant, with his patents paving the way for potential advancements in medical treatments. His work exemplifies the impact of innovation in addressing complex health issues.